Primary sclerosing cholangitis ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

Overview

Ultrasound may be done as part of the workup for primary sclerosing cholangitis. However, findings are nonspecific, non-diagnostic and may even be normal. However, approximately 40% of patients have associated gallbladder abnormalities, which may be identified on an abdominal ultrasound. These include thickening of the gallbladder wall, gallbladder enlargement, gallbladder stones (cholelithiasis), masses, and other findings suggestive of cholecystitis.

Ultrasound

Ultrasound may be done as part of the workup for primary sclerosing cholangitis. However, findings are nonspecific, non-diagnostic and may even be normal. However, approximately 40% of patients have associated gallbladder abnormalities, which may be identified on an abdominal ultrasound. These include thickening of the gallbladder wall, gallbladder enlargement, gallbladder stones (cholelithiasis), masses, and other findings suggestive of cholecystitis.^[1]^[2]^[3]^[4]

References

↑ Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010). “Diagnosis and management of primary sclerosing cholangitis”. Hepatology. 51 (2): 660–78. doi:10.1002/hep.23294. PMID 20101749.
↑ van de Meeberg PC, Portincasa P, Wolfhagen FH, van Erpecum KJ, VanBerge-Henegouwen GP (1996). “Increased gall bladder volume in primary sclerosing cholangitis”. Gut. 39 (4): 594–9. PMC 1383275. PMID 8944571.
↑ Said K, Glaumann H, Bergquist A (2008). “Gallbladder disease in patients with primary sclerosing cholangitis”. J. Hepatol. 48 (4): 598–605. doi:10.1016/j.jhep.2007.11.019. PMID 18222013.
↑ Prytz H, Keiding S, Björnsson E, Broomé U, Almer S, Castedal M, Munk OL (2006). “Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation”. Hepatology. 44 (6): 1572–80. doi:10.1002/hep.21433. PMID 17133469.

Template:WikiDoc Sources

[pmid20101749-1] Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010). “Diagnosis and management of primary sclerosing cholangitis”. Hepatology. 51 (2): 660–78. doi:10.1002/hep.23294. PMID 20101749.

[pmid8944571-2] van de Meeberg PC, Portincasa P, Wolfhagen FH, van Erpecum KJ, VanBerge-Henegouwen GP (1996). “Increased gall bladder volume in primary sclerosing cholangitis”. Gut. 39 (4): 594–9. PMC 1383275. PMID 8944571.

[pmid18222013-3] Said K, Glaumann H, Bergquist A (2008). “Gallbladder disease in patients with primary sclerosing cholangitis”. J. Hepatol. 48 (4): 598–605. doi:10.1016/j.jhep.2007.11.019. PMID 18222013.

[pmid17133469-4] Prytz H, Keiding S, Björnsson E, Broomé U, Almer S, Castedal M, Munk OL (2006). “Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation”. Hepatology. 44 (6): 1572–80. doi:10.1002/hep.21433. PMID 17133469.

[1]

[2]

[3]

[4]